Moreover, linear regression analysis showed that in WHO 2 grade CRC patients, the mean sCD40L concentration increased by 48% relative to the WHO 1 grade CRC patients, which strongly supports the role of sCD40L in colorectal cancer progression and may indicate this protein as a potential biomarker of colorectal cancer advancement. Here, CD40LG is linked to colorectal carcinoma.